CEGEDIM Signs Agreement for the Acquisition of SYNAVANT's Global Interactive Marketing Business.Business Editors/Health/Medical Writers PARIS--(BUSINESS WIRE)--March 17, 2003 CEGEDIM SA (CGDM CGDM Consortium on Green Design and Manufacturing .PA)(Euronext:CGM (1) (Computer Graphics Metafile) An ISO/IEC standard format for 2D graphics images introduced in 1987. Primarily a vector graphics format for technical illustrations and geophysical visualizations, CGM also supports raster graphics and text. 5350) CEGEDIM SA (Euronext:CGM 5350), global provider of value added Value Added The enhancement a company gives its product or service before offering the product to customers. Notes: This can either increase the products price or value. information and Customer Relationship Management (CRM (Customer Relationship Management) An integrated information system that is used to plan, schedule and control the presales and postsales activities in an organization. ) solutions for the pharmaceutical industry, announces the acquisition of the Interactive Marketing activities of SYNAVANT Inc, (Nasdaq:SNVT SNVT Standard Network Variable Types SNVT Short No Voltage Tester ) for $43.5 million. CEGEDIM is a multinational provider of technologies and services relating to relating to relate prep → concernant relating to relate prep → bezüglich +gen, mit Bezug auf +acc medical information for healthcare professionals and pharmaceutical companies. The acquisition of SYNAVANT's IM business strengthens CEGEDIM's position in North America North America, third largest continent (1990 est. pop. 365,000,000), c.9,400,000 sq mi (24,346,000 sq km), the northern of the two continents of the Western Hemisphere. and dovetails with its strategy to enhance its position as a global provider of medical information and direct marketing solutions in the healthcare sector. As part of the transaction, CEGEDIM will purchase the Pharbase(SM) database. SYNAVANT and CEGEDIM have also signed a long-term marketing and co-operation agreement whereby CEGEDIM will continue providing Pharbase(SM) for SYNAVANT's technology solutions and will benefit from data enrichment through these CRM or SFA See sales force automation. SFA - Sales Force Automation systems. CEGEDIM's expanded global presence and strengthened local support are expected to produce immediate benefits for IM customers, as well as current and future pharmaceutical clients. "This acquisition is a major step for CEGEDIM's activities in the United States United States, officially United States of America, republic (2005 est. pop. 295,734,000), 3,539,227 sq mi (9,166,598 sq km), North America. The United States is the world's third largest country in population and the fourth largest country in area. and will generate strong and complementary synergies with our present offerings, especially in Europe", says Jean-Claude LABRUNE, CEGEDIM's CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. . "We believe that both CEGEDIM's and IM's workforces worldwide are a core strength to achieve this enthusiastic project which perfectly fits our Group strategy." SYNAVANT's IM division is operating in 13 countries. For the twelve months ended September 2002, the acquired businesses generated approximately $50 million in revenue, net of postage rebilled to customers. Approximately 50% of this amount was generated in the United States. The transaction is subject to approval by SYNAVANT shareholders, regulatory approvals and other customary closing conditions. The Companies expect the transaction to close in the second or third quarter of 2003. SG Cowen Securities Corporation acted as financial advisor to CEGEDIM for this transaction. About CEGEDIM CEGEDIM is a global provider in value added information and CRM solutions for the pharmaceutical industry and healthcare professionals. The Group provides acknowledged expertise in state-of-the-art technologies such as IT and networks, databases management and the collect of complex and targeted key information for its healthcare customers. The Group's offerings essentially comprise recurrent services which are greatly enhanced by CEGEDIM's proprietary databases and result in a competitive advantage for its customers. With a presence in 29 countries and a workforce totaling more than 3300 people, the CEGEDIM Group has reported a turnover of EUR EUR In currencies, this is the abbreviation for the Euro. Notes: The currency market, also known as the Foreign Exchange market, is the largest financial market in the world, with a daily average volume of over US $1 trillion. 340 million in 2002. For any further information, please consult: http://www.cegedim.com About SYNAVANT SYNAVANT Inc. guides biopharmaceutical and healthcare companies globally to greater business success by accelerating the adoption of advances in healthcare around the world. SYNAVANT accomplishes this by designing, building and supporting a wide range of knowledge-based solution sets, that bring together leading-edge technology, proven data management competence, a full range of specialist services - including hardware services and computer systems validations - and over 30 years of healthcare expertise. Its comprehensive, global solutions include pharmaceutical Customer Relationship Management (CRM) and eBusiness applications, interactive marketing, server and database management, dedicated local helpline support, training, telemarketing, sample management, and product-recall services. SYNAVANT is headquartered in Atlanta, GA, USA and has offices in 21 countries. Additional information is available at http://www.synavant.com |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion